Insufficient scRNA-seq data for expression of FLG2 at single-cell level.
Insufficient scRNA-seq data for expression of FLG2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| skin | 87% | 114981.57 | 1581 / 1809 | 10% | 5.97 | 45 / 472 |
| esophagus | 78% | 82.60 | 1132 / 1445 | 8% | 0.35 | 15 / 183 |
| heart | 79% | 55.83 | 676 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 78% | 100.11 | 1047 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 77% | 124.23 | 929 / 1204 | 0% | 0 | 0 / 0 |
| breast | 76% | 49.37 | 349 / 459 | 1% | 0.12 | 8 / 1118 |
| ovary | 76% | 47.06 | 137 / 180 | 0% | 0 | 0 / 430 |
| muscle | 72% | 88.58 | 579 / 803 | 0% | 0 | 0 / 0 |
| uterus | 68% | 41.06 | 116 / 170 | 2% | 0.08 | 10 / 459 |
| thymus | 67% | 46.40 | 438 / 653 | 0% | 0 | 0 / 605 |
| pancreas | 66% | 44.53 | 217 / 328 | 0% | 0 | 0 / 178 |
| stomach | 65% | 40.88 | 232 / 359 | 1% | 0.01 | 2 / 286 |
| lung | 58% | 62.17 | 337 / 578 | 1% | 0.03 | 13 / 1155 |
| intestine | 58% | 41.65 | 562 / 966 | 1% | 0.04 | 4 / 527 |
| prostate | 56% | 27.56 | 136 / 245 | 0% | 0.01 | 2 / 502 |
| adrenal gland | 53% | 31.83 | 138 / 258 | 0% | 0 | 0 / 230 |
| peripheral blood | 45% | 26.34 | 416 / 929 | 0% | 0 | 0 / 0 |
| liver | 41% | 35.49 | 93 / 226 | 0% | 0 | 0 / 406 |
| brain | 40% | 26.47 | 1047 / 2642 | 0% | 0 | 0 / 705 |
| spleen | 39% | 21.23 | 95 / 241 | 0% | 0 | 0 / 0 |
| kidney | 30% | 16.92 | 27 / 89 | 0% | 0.00 | 2 / 901 |
| bladder | 29% | 9.71 | 6 / 21 | 1% | 0.10 | 7 / 504 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0048730 | Biological process | epidermis morphogenesis |
| GO_0007155 | Biological process | cell adhesion |
| GO_0061436 | Biological process | establishment of skin barrier |
| GO_0001533 | Cellular component | cornified envelope |
| GO_1904724 | Cellular component | tertiary granule lumen |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0036457 | Cellular component | keratohyalin granule |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005634 | Cellular component | nucleus |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0046914 | Molecular function | transition metal ion binding |
| GO_0005198 | Molecular function | structural molecule activity |
| Gene name | FLG2 |
| Protein name | Alternative protein FLG2 Filaggrin-2 (FLG-2) (Intermediate filament-associated and psoriasis-susceptibility protein) (Ifapsoriasin) |
| Synonyms | IFPS |
| Description | FUNCTION: Essential for normal cell-cell adhesion in the cornified cell layers . Important for proper integrity and mechanical strength of the stratum corneum of the epidermis . . |
| Accessions | L8E7D3 ENST00000388718.5 Q5D862 |